TETRATHERIX

Tetratherix is an Australian medtech pioneer that has developed an advanced biomaterial platform called Tetramatrix... Tetratherix's hydrogel technology used as an enabling carrier for targeted delivery of novel therapeutics. This is an exciting development in our Biodelivery program and validates the potential of our technology to effectively deliver & preserve the bioactivity of a range of therapeutics - Journal of Pharmaceutics... While leading the development and commercialization of innovations in regenerative medicine, Will Knox was introduced to Tetratherix in 2018. Will's experience in managing global commercialization of medtech shaped a unique appreciation for the technology's wide-reaching clinical benefit and exciting market potential. The founding team was completed by Will's appointment as CEO which provides the commercial context to define and deliver the Tetratherix mission, vision and culture. Leading innovation in regenerative medicine and with a clear path to..

Also known as: Tetratherix Pty Ltd.

Primary location: Los Angeles United States